Entity family

Browse diseases

Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.

570articles mentioning diseases

2,756disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: SLE ×

SLE

This disease is selected. Its supporting articles are shown below.

Articles mentioning SLE

570 articles · page 42 of 48

PO:13:350 Perceptions of live-online fatigue management programmes versus standard care in people with systemic lupus erythematosus: preliminary findings from the FLIP study

lupusscimed · abstract · 2026-03-01 · 2 matching annotations

98.3%

SLE Lupus FMP 7W FMP Abstarct PO FMPs

…l for fatigue management than standard care. People living with SLE in the UK have a preference for live-online group FMPs than sta…

PO:13:351 Financial burden of systemic lupus erythematosus management on patients: insights from a North African (Tunisian) community

lupusscimed · abstract · 2026-03-01 · 2 matching annotations

94.5%

SLE tunisian SLE hydroxychloroquine Facebook support group

… questionnaire form via the Facebook support group for tunisian SLE patients. The questionnaire included sections about patients ch…

PT2:05 High risk apolipoprotein L1 genetic variants are associated with the occurrence of lupus nephritis: a case-control study

lupusscimed · abstract · 2026-03-01 · 2 matching annotations

83.5%

Lupus nephritis systemic lupus erythematosus SLE LN

…Objectives Lupus nephritis (LN) is more common in Black than in White ethnic groups. High …

PT3:02 Predictors of flare in systemic lupus erythematosus after glucocorticoid tapering or withdrawal: a retrospective cohort study

lupusscimed · abstract · 2026-03-01 · 2 matching annotations

99.0%

SLE hydroxychloroquine Coimbra’s Hospital PDN prednisolone

…N) tapering versus maintenance of low-dose PDN on flare risk in SLE patients in remission.Methods Observational, retrospective coho…

PT3:07 Sociodemographic, clinical and biomarker predictors of cognitive performance in lupus

lupusscimed · abstract · 2026-03-01 · 2 matching annotations

92.8%

systemic lupus erythematosus SLE lupus glucocorticoids antimalarials biologics immunosuppressants

… determinants influencing longitudinal cognitive performance in systemic lupus erythematosus (SLE), evaluated globally and across distinct cognitive domains…

PT7:07 Digital-BILAG: making BILAG-2004 practical for routine care and clinical trial use

lupusscimed · abstract · 2026-03-01 · 2 matching annotations

99.1%

SLE lupus BILAG-2004 BILAG

…trengthen endpoint reliability—key barriers implicated in prior SLE trial failures.…

PT7:08 Longitudinal association between LLDAS and remission attainment and improvement in health-related quality of life in patients with systemic lupus erythematosus:a multinational prospective cohort study

lupusscimed · abstract · 2026-03-01 · 2 matching annotations

87.3%

systemic lupus erythematosus SLE Asia Pacific Lupus Collaboration APLC

…ives Attainment of validated treat-to-target (T2T) endpoints in systemic lupus erythematosus (SLE), such as lupus low disease activity state (LLDAS) and rem…

S13:01 The novel SLE-DAS responder index aligns clinical endpoints with patient experience and outperforms BICLA and SRI-4 in capturing HRQoL: post-hoc analysis in the MUSE, TULIP-1 and TULIP-2 trials

lupusscimed · abstract · 2026-03-01 · 2 matching annotations

98.2%

SLE SLE-DAS MSDA

…ue for HR-QoL supports its use as a next-generation endpoint in SLE trials. SLE-DAS accurately classifies MSDA, supporting use in e…

S13:02 Advancing arthritis assessment in SLE clinical trials: derivation, validation and proposed thresholds of the lupus arthritis and musculoskeletal disease activity (LAMDA) instrument

lupusscimed · abstract · 2026-03-01 · 2 matching annotations

94.7%

lupus arthritis SLE rheumatoid arthritis glucocorticoid therapy Visual Analogue Scale LAMDA LAMDA28

… clinical disease activity measure to improve the assessment of lupus arthritis. Further validation is underway in multinational RCTs. LAMDA wa…

S9:05 Lessons from a specialized lupus clinic: presentation and damage outcomes in inception vs. prevalent lupus nephritis cohorts

lupusscimed · abstract · 2026-03-01 · 2 matching annotations

83.3%

systemic lupus erythematosus SLE lupus nephritis LN glucocorticoid glucocorticoid-related

…cialized lupus clinics has been proposed to improve outcomes in systemic lupus erythematosus (SLE). This study compared clinical presentations and long-term…

Alterations in the DTI-ALPS index and choroid plexus volume as brain–immune interfacing indicators in neuropsychiatric lupus erythematosus with inflammatory phenotype

lupusscimed · abstract · 2026-01-28 · 2 matching annotations

89.5%

SLE neuropsychiatric systemic lupus erythematosus NPSLE

…ry subtypes. CP volume is significantly higher in patients with SLE than in HCs (L: F=22.273, p<0.001; R: F=21.176, p<0.001). ROC a…

Successful autologous CD19 CAR T cell therapy following severe lupus flare during immunosuppressive washout in refractory lupus nephritis

lupusscimed · abstract · 2025-11-19 · 2 matching annotations

96.1%

SLE lupus nephritis lupus podocytopathy lupus obinutuzumab belimumab rituximab pulse methylprednisolone CD19 chimeric antigen receptor (CAR) T cell therapy

… day 7). The patient achieved sustained clinical remission with SLE Disease Activity Index Score decreasing from 17 prior to leukap…